Press "Enter" to skip to content

The effect of preimplantation genetic testing for aneuploidy (PGT-A) on in vitro fertilization (IVF) outcomes with donor oocytes and utilization of elective single embryo transfer (ESET)

The effect of preimplantation genetic testing for aneuploidy (PGT-A) on in vitro fertilization (IVF) outcomes with donor oocytes and utilization of elective single embryo transfer (ESET)
Aneuploidy is a known detrimental factor limiting embryo implantation in patients undergoing IVF. As such, PGT-A has been shown to be a successful strategy to improve rates of embryo implantation and reduce the risk of miscarriage. ESET has also been shown to reduce the morbidity and mortality that is associated with multiple gestations. ESET with PGT-A has been well-studied among patients undergoing IVF with autologous oocytes, but few studies have examined the use of PGT-A with donor oocytes (DO).
Source: fertstert.org

Be First to Comment